Transfusion practice in dogs and cats: an Internet‐based survey

Jagodich, Tiffany A.; Holowaychuk, Marie K.

doi:10.1111/vec.12451

Cited by 36 publications

(42 citation statements)

References 44 publications

(103 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Thus, staff at many veterinary hospitals perform crossmatches in dogs only 3 to 5 days after the first transfusion or in those with an unknown transfusion history, but do not test routinely before the first transfusion. 16 In 1913, Ottenberg et al 17 first demonstrated what was likely naturally occurring isoagglutinins and hemolysins in dogs. They described the agglutination and hemolysis to be weaker than that typically found in rats, rabbits, and people.…”

Section: Discussionmentioning

confidence: 99%

“…[13][14][15] In fact, the results of an online survey of participants from 73 veterinary referral or teaching hospitals indicate that only 11 of 73 (15%) performed a crossmatch evaluation for all dogs prior to transfusion. 16 Results from that study 16 suggest that veterinarians in most clinics do not routinely perform this evaluation for dogs that have not previously undergone a transfusion (ie, naïve recipients), although 72 of 73 (99%) respondents reported that they perform a crossmatch 3 to 5 days after the first transfusion has been given to a dog.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Incidence of incompatible crossmatch results in dogs admitted to a veterinary teaching hospital with no history of prior red blood cell transfusion

Odunayo¹,

Garraway²,

Rohrbach³

et al. 2017

javma

View full text Add to dashboard Cite

OBJECTIVE To determine the incidence of incompatible crossmatch results in dogs without a history of prior RBC transfusion and to evaluate changes in Hct following RBC administration for transfusion-naïve dogs that did and did not have crossmatching performed. DESIGN Retrospective study. ANIMALS 169 client-owned dogs. PROCEDURES Information obtained from the medical records included signalment, pretransfusion Hct or PCV, and crossmatching results where applicable. Dogs that underwent major crossmatching (n = 149) as part of pretransfusion screening were each crossmatched with 3 potential donors. Donor blood was obtained from a commercial source and tested negative for dog erythrocyte antigens (DEAs) 1.1, 1.2, and 7 but positive for DEA 4. Mean change in Hct after transfusion was compared between crossmatch-tested dogs (57/91 that subsequently underwent RBC transfusion) and 20 other dogs that underwent RBC transfusion without prior crossmatching by statistical methods. RESULTS 25 of 149 (17%) dogs evaluated by crossmatching were incompatible with 1 or 2 of the 3 potential donors. All 149 dogs were compatible with ≥ 1 potential donor. Mean ± SD change in Hct after transfusion was significantly higher in dogs that had crossmatching performed (12.5 ± 8.6%) than in dogs that did not undergo crossmatching (9.0 ± 4.3%). CONCLUSIONS AND CLINICAL RELEVANCE Results indicated immunologic incompatibility can exist between first-time transfusion recipients and potential blood donor dogs. The clinical importance of these findings could not be evaluated, but considering the potential for immediate or delayed hemolytic transfusion reactions or shortened RBC life span, the authors suggest veterinarians consider crossmatching all dogs prior to transfusion when possible.

show abstract

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

Incidence of incompatible crossmatch results in dogs admitted to a veterinary teaching hospital with no history of prior red blood cell transfusion

Odunayo¹,

Garraway²,

Rohrbach³

et al. 2017

javma

View full text Add to dashboard Cite

show abstract

“…In clinical veterinary medicine, plasma has traditionally been thawed using either controlled temperature WWBs or unregulated running warm water. A recent veterinary referral practice survey showed that the majority of blood products are warmed using WWBs while a few hospitals use commercial heating devices (Jagodich & Holowaychuk 2016). To our knowledge, there are no published guidelines for thawing FFP in veterinary medicine.…”

Section: Discussionmentioning

confidence: 99%

Comparison of multiple thawing techniques on thaw time and stability of hemostatic proteins in canine plasma products

Torkildsen

Bishop²,

Barr³

et al. 2018

J of Small Animal Practice

View full text Add to dashboard Cite

show abstract

“…A terapia transfusional veterinária consiste na transfusão de sangue total ou hemocomponentes de um doador para um receptor, sendo indicada para cães em casos como sangramentos agudos, com o intuito de reparar a oxigenação, prevenir sangramentos e reestabalecer a homeostase; hematócrito muito baixo (menor ou igual a 15%); hemoglobina menor ou igual a 4g/ml; perda de mais de 30% do volume de sangue total; hipovolemia entre outros fatores que lançam a necessidade de uma transfusão sanguínea (HANN et al, 2014;HOHENHAUS, 2004;JAGODICH;HOLO-WAYCHUK, 2016).…”

Section: Terapia Transfusional E a Importância Da Determinação Dos Anunclassified

Imunohematologia Veterinária: Antígenos Eritrocitários Caninos

Vizzoni

Medeiros

2017

ArqVet

View full text Add to dashboard Cite

A imunohematologia veterinária vem ganhando interesse nos últimos anos devido a maior acessibilidade a tecnologias de detecção de antígenos e anticorpos, interesse dos donos e médicos veterinários em buscar uma melhor qualidade de vida para os animais e as necessidades de transfusões com o menor índice possível de reações indesejadas. Os cães possuem antígenos presentes na membrana de suas células vermelhas, podendo causar reações durante e após transfusões. Diferentemente de humanos e felinos, cães não possuem anticorpos naturais para os principais antígenos, a priori podendo ser transfundidos com qualquer tipo sanguíneo sem consequências posteriores, porém, se submetidos a uma segunda transfusão, sendo essa de um tipo sanguíneo incompatível e previamente sensibilizados, as chances de ocorrer reações transfusionais graves aumentam drasticamente, ocasionando danos ao animal, podendo levá-lo à morte. Por conta desses riscos se faz necessário uma maior atenção aos tipos sanguíneos desses animais onde 8 sistemas são reconhecidos internacionalmente classificados como sistema DEA, sendo eles DEA 1 e seus subtipos (DEA 1.1; DEA1.2; DEA 1.3); DEA 3; DEA 4; DEA 5; DEA 6; DEA 7 e DEA 8, e recentemente um novo sistema denominado Dal. Não há disponível ainda soros para os sistemas DEA 6 e DEA 8, tornando a pesquisa sobre esses antígenos dificultosa.

show abstract

Transfusion practice in dogs and cats: an Internet‐based survey

Cited by 36 publications

References 44 publications

Incidence of incompatible crossmatch results in dogs admitted to a veterinary teaching hospital with no history of prior red blood cell transfusion

Incidence of incompatible crossmatch results in dogs admitted to a veterinary teaching hospital with no history of prior red blood cell transfusion

Comparison of multiple thawing techniques on thaw time and stability of hemostatic proteins in canine plasma products

Imunohematologia Veterinária: Antígenos Eritrocitários Caninos

Contact Info

Product

Resources

About